On HD 67, both IL-2 and IL-6 were elevated (1,060 and 12,376 pg/mL, respectively; the last dose of tocilizumab was 12 days earlier) and the following day extreme hyperferritinemia (31,085 ng/mL) was noted a fourth time. This evidence concerns the gene IL2 and isolated hyperferritinemia.